Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
about
Cif is negatively regulated by the TetR family repressor CifRExhaled Breath Condensate: Technical and Diagnostic AspectsMUC5AC mucin release from human airways in vitro: effects of indomethacin and Bay X1005Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary diseasePulmonary diseases other than asthma as potential targets for antileukotriene therapy.Novel approaches and targets for treatment of chronic obstructive pulmonary disease.Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.Novel therapy for COPD.Exhaled leukotrienes and prostaglandins in COPD.New therapies for chronic obstructive pulmonary diseaseExhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary diseaseMetabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.Chest pain and exacerbations of bronchiectasis.Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications.Leukotrienes and inflammatory lung disease.Application of metabolomics approaches to the study of respiratory diseases.Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretionLeukotrienes in the sputum and urine of cystic fibrosis children.Leukotriene B4 and asthma.Dark nights behind the white clouds - risks of tobacco smoking on human health besides the oral health and malignancy.Leukotriene receptor antagonists: clinical effects.New therapeutic indications for Cys-LT1 antagonists: chronic obstructive pulmonary disease
P2860
Q24646990-1B142B41-A03E-4638-BB44-8E89CC126972Q28082250-A58BBBAB-D5F3-4B64-85F8-58ABA4807B30Q28363654-75D0082A-A21F-4D19-8650-5B79EF97EE1AQ33634172-2554C5C5-EE76-4184-9669-9F34DC24BA6FQ33705523-5C398300-0967-450D-A891-2EF4290DDA3EQ33771480-EB9D2675-BC5B-42D3-9BEA-10DA58236AE2Q33820309-BDFDD2FE-0283-4FFC-B6E6-EFCD36174CE2Q34074654-D5C7D768-CEC3-4E2A-91C4-AA170F8C86E9Q35536034-69C7601C-E5E7-4FCB-96D8-0462FD6CE60CQ35563923-DEB28B72-A460-4311-92DC-230D95F7D928Q35990445-2CD862C3-6512-4F94-AB73-EA8F3DB3A242Q36142593-62601E3F-F716-40A0-AA19-E2A00C58E37CQ36479483-C9E7B1E5-C564-4A30-9C38-16DFAD50E00BQ37362565-4A97458A-6ECD-442C-8F15-1BB9679EA508Q37518949-84C099B7-ABF0-460D-B256-C4432293A8D6Q38050515-0ECD46C0-526E-4D77-B477-08D2E6057A1EQ39807933-0C2D6890-D847-4156-A75D-16321AB24B20Q41972684-06A7917E-7A8A-44CE-A10B-48A0322C6DFFQ42423750-19EF02C2-9B36-4DDF-8529-5688C8191587Q42920767-B8C870B1-6940-406C-AE50-273CFAD6221AQ55686747-08AF9F7E-E9A1-4B33-8A37-0621CFEEB3D8Q58877319-8E7F3290-C5CB-4E72-B306-CA13FCF3D9B6
P2860
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@en
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@nl
type
label
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@en
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@nl
prefLabel
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@en
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1476
Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.
@en
P2093
Costello JF
Zakrzewski JT
P2860
P304
P356
10.1164/AJRCCM/136.3.779
P577
1987-09-01T00:00:00Z